Related Experiment Video
Updated: May 8, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Membranous nephropathy that first presented in pregnancy
Yumie Aoshima1, Masayuki Iyoda, Ai Nakazawa
1Department of Medicine, Showa University School of Medicine, Japan.
Idiopathic membranous nephropathy (MN) can develop during pregnancy, presenting as nephrotic syndrome (NS). Early diagnosis and management, including considering pregnancy termination, may lead to partial remission of NS.
Area of Science:
- Nephrology
- Obstetrics & Gynecology
- Pathology
Background:
- Pregnancy can unmask or exacerbate underlying renal conditions.
- Nephrotic syndrome (NS) during pregnancy requires careful evaluation for underlying causes.
- Idiopathic membranous nephropathy (MN) is a potential cause of NS.
Observation:
- A 37-year-old pregnant woman presented with proteinuria and hematuria at 13 weeks gestation.
- Proteinuria progressed to nephrotic syndrome (NS) by 17 weeks gestation, unresponsive to prednisolone and methylprednisolone pulse therapy.
- The patient underwent elective abortion at 21 weeks gestation, after which NS showed partial remission.
Findings:
- Renal biopsy confirmed membranous nephropathy (MN).
- No secondary causes of MN were identified.
- This case represents the first report of subclinical idiopathic MN developing during pregnancy.
Implications:
- Pregnancy-associated nephrotic syndrome warrants thorough investigation for idiopathic membranous nephropathy.
- Management strategies may need to consider the impact on both maternal renal health and pregnancy.
- This case highlights the importance of recognizing idiopathic MN as a potential complication of pregnancy.
More Related Videos
05:31Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Diabetic Nephropathy
Nephrotic Syndrome I : Introduction
Nephrons
Chronic Kidney Disease II: Clinical Manifestations
Diabetic Retinopathy
Nephrotic Syndrome II : Assessment and Medical Management